Kitamura, Hiroshi <br/><br/>
Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients.  [electronic resource] 

 -  International journal of urology : official journal of the Japanese Urological Association  Oct 2015 
 - 911-4 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1442-2042 
<br/><br/><label>Standard No.: </label>10.1111/iju.12842  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiemetics--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Aprepitant<br/>Carcinoma, Transitional Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Dexamethasone--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Granisetron--therapeutic use<br/>Humans<br/>Isoquinolines--therapeutic use<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Morpholines--therapeutic use<br/>Nausea--chemically induced<br/>Ondansetron--therapeutic use<br/>Palonosetron<br/>Quinuclidines--therapeutic use<br/>Retrospective Studies<br/>Serotonin 5-HT3 Receptor Antagonists--therapeutic use<br/>Serotonin Antagonists--therapeutic use<br/>Ureteral Neoplasms--drug therapy<br/>Urinary Bladder Neoplasms--drug therapy<br/>Urologic Neoplasms--drug therapy<br/>Vomiting--chemically induced<br/>Gemcitabine